SILC:NASDAQSilicom Ltd Analysis
Data as of 2026-05-27 - not real-time
$47.06
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Silicom Ltd. (SILC) is trading at $47.06, comfortably above its 20‑day, 50‑day and 200‑day moving averages of $43.57, $31.56 and $20.46 respectively, indicating a strong bullish bias. The RSI sits at 63.9, leaving room for upside before overbought conditions, while the MACD histogram is slightly negative, hinting at a short‑term pull‑back. Volatility is exceptionally high at 127% over the past 30 days and beta is 1.61, underscoring pronounced price swings and market sensitivity. Fundamentally, the company posted a 33% year‑over‑year revenue increase to $66.6 M, but continues to operate at a loss with operating margin of –14.7% and negative EPS, while holding $35 M in cash against $6.6 M of debt.
Recent material news highlights a "mega" order that accelerated revenue growth, a $5 M/year design win with a Tier‑1 cyber‑security leader, and adoption of Silicom’s AI inference acceleration solution, all of which could fuel top‑line expansion. However, the lack of profitability, high leverage (debt‑to‑equity 5.69), and zero dividend support a cautious outlook despite the positive momentum.
Recent material news highlights a "mega" order that accelerated revenue growth, a $5 M/year design win with a Tier‑1 cyber‑security leader, and adoption of Silicom’s AI inference acceleration solution, all of which could fuel top‑line expansion. However, the lack of profitability, high leverage (debt‑to‑equity 5.69), and zero dividend support a cautious outlook despite the positive momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above all major moving averages
- MACD bearish divergence suggesting near‑term pullback
- High short‑term volatility and beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 33% revenue growth driven by large design wins
- Strong cash position relative to modest debt
- Strategic AI and cyber‑security product adoption expanding addressable market
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Persistent operating losses and negative margins
- Potential for profitability if growth initiatives materialize
- Elevated valuation metrics for a loss‑making company
Key Metrics & Analysis
Financial Health
Revenue Growth32.80%
Profit Margin-16.57%
P/E Ratio-102.3
ROE-9.17%
ROA-4.80%
Debt/Equity5.69
P/B Ratio2.3
Industry P/E40.4
Technical Analysis
TrendBullish
RSI63.9
Support$27.10
Resistance$52.58
MA 20$43.57
MA 50$31.56
MA 200$20.46
MACDBearish
VolumeStable
Fear & Greed Index92.34
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.61
Volatility127.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.